Stock Scorecard
Stock Summary for Zimmer Biomet Holdings Inc (ZBH) - $109.27 as of 11/20/2024 8:55:12 PM EST
Total Score
14 out of 30
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for ZBH
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ZBH
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ZBH
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ZBH
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ZBH (61 out of 90)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 9 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 1 |
| Operating Margin (Max of 10) | 4 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 7 |
Latest News for for ZBH
Financial Details for ZBH
Company Overview |
|
|---|---|
| Ticker | ZBH |
| Company Name | Zimmer Biomet Holdings Inc |
| Country | USA |
| Description | Zimmer Biomet is a publicly traded medical device company. The company is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. |
| Sector Name | LIFE SCIENCES |
| Industry Name | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | 2/6/2025 |
Stock Price History |
|
| Last Day Price | 109.27 |
| Price 4 Years Ago | 145.39 |
| Last Day Price Updated | 11/20/2024 8:55:12 PM EST |
| Last Day Volume | 1,450,867 |
| Average Daily Volume | 1,502,916 |
| 52-Week High | 133.31 |
| 52-Week Low | 101.47 |
| Last Price to 52 Week Low | 7.69% |
Valuation Measures |
|
| Trailing PE | 21.57 |
| Industry PE | 42.00 |
| Sector PE | 40.32 |
| 5-Year Average PE | 19.05 |
| Free Cash Flow Ratio | 38.21 |
| Industry Free Cash Flow Ratio | 29.06 |
| Sector Free Cash Flow Ratio | 27.97 |
| Current Ratio Most Recent Quarter | 1.36 |
| Total Cash Per Share | 2.86 |
| Book Value Per Share Most Recent Quarter | 62.00 |
| Price to Book Ratio | 1.81 |
| Industry Price to Book Ratio | 4.07 |
| Sector Price to Book Ratio | 20.88 |
| Price to Sales Ratio Twelve Trailing Months | 2.95 |
| Industry Price to Sales Ratio Twelve Trailing Months | 5.29 |
| Sector Price to Sales Ratio Twelve Trailing Months | 7.11 |
| Analyst Buy Ratings | 6 |
| Analyst Strong Buy Ratings | 4 |
Share Statistics |
|
| Total Shares Outstanding | 199,074,000 |
| Market Capitalization | 21,752,815,980 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 9/30/2024 |
| Last Dividend Amount | 0.24 |
| Current Dividend Amount | 0.24 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.96 |
| Trailing Annual Dividend Yield | 0.88% |
| Forward Annual Dividend Rate | 0.96 |
| Forward Annual Dividend Yield | 0.88% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 0.77% |
| 5-Year Average Dividend Yield | 0.72% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 2.65% |
| Dividend Payout Ratio | 18.32% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 59.70% |
| Annual Earnings Growth | 342.52% |
| Reported EPS 12 Trailing Months | 5.24 |
| Reported EPS Past Year | 5.69 |
| Reported EPS Prior Year | 7.56 |
| Net Income Twelve Trailing Months | 1,083,500,000 |
| Net Income Past Year | 1,024,000,000 |
| Net Income Prior Year | 231,400,000 |
| Quarterly Revenue Growth YOY | 4.00% |
| 5-Year Revenue Growth | -1.16% |
| Operating Margin Twelve Trailing Months | 0.18 |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 569,000,000 |
| Total Cash Past Year | 415,800,000 |
| Total Cash Prior Year | 375,700,000 |
| Net Cash Position Most Recent Quarter | -7,585,800,000 |
| Net Cash Position Past Year | -6,086,300,000 |
| Long Term Debt Past Year | 6,502,100,000 |
| Long Term Debt Prior Year | 5,453,300,000 |
| Total Debt Most Recent Quarter | 8,154,800,000 |
| Equity to Debt Ratio Past Year | 0.66 |
| Equity to Debt Ratio Most Recent Quarter | 0.60 |
| Total Stockholder Equity Past Year | 12,480,500,000 |
| Total Stockholder Equity Prior Year | 12,020,300,000 |
| Total Stockholder Equity Most Recent Quarter | 12,374,700,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,931,600,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 9.70 |
| Free Cash Flow Past Year | 2,884,500,000 |
| Free Cash Flow Prior Year | 2,049,200,000 |
Options |
|
| Put/Call Ratio | 2.29 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 1.07 |
| MACD Signal | 0.75 |
| 20-Day Bollinger Lower Band | 101.62 |
| 20-Day Bollinger Middle Band | 108.09 |
| 20-Day Bollinger Upper Band | 114.56 |
| Beta | 1.02 |
| RSI | 57.79 |
| 50-Day SMA | 115.50 |
| 150-Day SMA | 117.68 |
| 200-Day SMA | 124.53 |
System |
|
| Modified | 11/19/2024 4:55:58 PM EST |